Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

McMaster University

$240,976.00

Systematic Reviews & Network Meta-Analyses to Support Optimal Management of Bacterial Infections

FY 2024-25

Summary
Antimicrobial resistance is a serious global throat caused by bacteria adapting to tolerate antibiotics. Overuse and misuse of these medicines accelerate this process, jeopardizing our ability to manage infections effectively. Without reliable antibiotics, even minor infections may become life-threatening, reversing a century of medical progress. In response, experts globally are creating strategies to use antibiotics more prudently. In Canada, the Public Health Agency of Canada (PHAC) and the Association of Medical Microbiology and Infectious Disease Canada (AMMI Canada) identified 30 common infections that importantly contribute to antibiotic use. They are establishing updated treatment guidelines for these infections to help healthcare providers prescribe antibiotics responsibly. However, for these guidelines to be trustworthy, they must base recommendations on comprehensive and rigorous systematic reviews and meta-analyses-studies that identify, appraise, and pool the results of studies addressing the same research question. Currently, no high-quality reviews exist for four key infections that account for a large share of antibiotic prescriptions: childhood community-acquired pneumonia, pharyngitis, sinusitis, and acute exacerbations of chronic obstructive pulmonary disease. Our project will address this gap. We bring together a diverse team of physicians, pharmacists, public health experts, patient partners, and research methodologists to produce comprehensive and rigorous systematic reviews. For each syndrome, we will search medical databases for relevant studies, evaluate each study's quality, and then synthesize all available evidence. We will conduct network meta-analyses, enabling us to compare multiple antibiotics-even those never tested head-to-head-across a network of trials. Our findings will inform Canada's guidelines and advance global efforts to preserve antibiotic effectiveness by helping physicians make more informed prescribing decisions.
Program
Project Grant
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
522740
Name
Zeraatkar Dena
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Clinical
Prcname2
Health Services Evaluation & Interventions Research
Projecttitle
Systematic Reviews & Network Meta-Analyses to Support Optimal Management of Bacterial Infections
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$240,976
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Antibiotics; Copd; Network Meta-Analysis; Pharyngitis; Pneumonia; Sinusitis; Systematic Review
Abstract
Antimicrobial resistance is a serious global throat caused by bacteria adapting to tolerate antibiotics. Overuse and misuse of these medicines accelerate this process, jeopardizing our ability to manage infections effectively. Without reliable antibiotics, even minor infections may become life-threatening, reversing a century of medical progress. In response, experts globally are creating strategies to use antibiotics more prudently. In Canada, the Public Health Agency of Canada (PHAC) and the Association of Medical Microbiology and Infectious Disease Canada (AMMI Canada) identified 30 common infections that importantly contribute to antibiotic use. They are establishing updated treatment guidelines for these infections to help healthcare providers prescribe antibiotics responsibly. However, for these guidelines to be trustworthy, they must base recommendations on comprehensive and rigorous systematic reviews and meta-analyses-studies that identify, appraise, and pool the results of studies addressing the same research question. Currently, no high-quality reviews exist for four key infections that account for a large share of antibiotic prescriptions: childhood community-acquired pneumonia, pharyngitis, sinusitis, and acute exacerbations of chronic obstructive pulmonary disease. Our project will address this gap. We bring together a diverse team of physicians, pharmacists, public health experts, patient partners, and research methodologists to produce comprehensive and rigorous systematic reviews. For each syndrome, we will search medical databases for relevant studies, evaluate each study's quality, and then synthesize all available evidence. We will conduct network meta-analyses, enabling us to compare multiple antibiotics-even those never tested head-to-head-across a network of trials. Our findings will inform Canada's guidelines and advance global efforts to preserve antibiotic effectiveness by helping physicians make more informed prescribing decisions.
Competitiondate
202503
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Zeraatkar, Dena; Langford, Bradley J; Loeb, Mark B; Yamamura, Deborah L
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $240,976~ $0~